May 28 |
CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK
|
May 26 |
CureVac N.V. (NASDAQ:CVAC) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
|
May 25 |
CureVac First Quarter 2024 Earnings: Misses Expectations
|
May 23 |
CureVac: Remains A Hold Based On Bird Flu Vaccine And Oncology Advancements
|
May 23 |
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
|
May 23 |
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
|
May 23 |
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
|
May 22 |
Moderna, BioNTech close with double-digit percentage gains amid bird flu fears
|
May 22 |
Australia reports first human case of bird flu
|
May 17 |
Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
|